Form 4: Aspira Women's Health CEO Nicole Sandford Granted Stock Options
SEC Form 4
Aspira Women's Health CEO Nicole Sandford was granted stock options to purchase 80,000 shares of common stock on May 13, 2024.
Summary
- Nicole Sandford, CEO of Aspira Women's Health Inc., was granted employee stock options on May 13, 2024.
- The options allow her to purchase 80,000 shares of Aspira Women's Health common stock at an exercise price of $2.88 per share.
- The options vest in equal monthly installments over four years, starting June 13, 2024, and expire on May 13, 2034.
- Following this transaction, Sandford directly owns 80,000 derivative securities.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The granting of stock options is a routine part of executive compensation and signals confidence in the company's future performance.
Positives
- The granting of stock options to the CEO aligns her interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the CEO.
Future Outlook
The document does not contain any specific forward-looking statements or guidance.
Industry Context
Granting stock options to executives is a common practice in the healthcare industry to incentivize performance and align management's interests with shareholders.
Comparison to Industry Standards
- Stock option grants are a typical component of executive compensation packages in publicly traded companies, especially in growth-oriented sectors like women's health.
- The vesting schedule of four years is fairly standard, aligning with typical long-term incentive plans.
- Comparable companies in the diagnostics and women's health space, such as Hologic or Exact Sciences, also utilize stock options as part of their executive compensation strategy.
Stakeholder Impact
- Shareholders may view the stock option grant as a positive incentive for the CEO to drive long-term value.
- Employees may see the grant as a sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 05/13/2024 | Date of the stock option grant. |
| 06/13/2024 | Start date for the monthly vesting of the stock options. |
| 05/13/2034 | Expiration date of the stock options. |
| 05/14/2024 | Date of signature on the Form 4. |
Keywords
stock options, Aspira Women's Health, CEO, Nicole Sandford, Form 4, executive compensation, equity
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.